Great research news from @UCSFcmfpm and @MackenzieTippi — case study on in utero enzyme replacement treatment of a fetus with infantile-onset Pompe—a lysosomal storage disease.
Infantile-onset Pompe’s disease is caused by a genetic deficiency of an enzyme critical to heart development. This case study involved the intrauterine treatment of an affected fetus with enzyme replacement at approximately 6 months of gestation. https://t.co/knVoqLrIMC
Excited to share @MacKenzieTippi and team’s @NEJM case study, describing in utero enzyme replacement treatment of a fetus with infantile-onset Pompe—a lysosomal storage disease. The results encourage further investigation of prenatal therapy. https://t.co/ae9xVO1LrP
RESEARCH NEWS: In 2020 Ayla was diagnosed w/ a deadly disease before she was born, but her mom couldn't travel to our hospital for care due to the pandemic. Dr. @MackenzieTippi shared her protocol with MDs in Ottawa & gave Ayla a chance at a healthy life! https://t.co/fmAOmRsiLf
We are excited to be back in person exhibiting at ACOG’s annual conference in San Diego. If you are attending, be sure to stop by and learn about our unique offerings.
#ACOG2022
We are excited to be part of #SMFM2020 this year. We have a number of presentations and poster sessions. Check out our schedule here: https://t.co/KUtJSVavZh
Watch our new webinar Fetal Care: Understanding and Managing Risks with Monochorionic Twins webinar with Vickie Feldstein, MD and Nasim Sobhani, MD! https://t.co/IBubS1TQXh
Join us Dec 1, 2021 12:30pm for our next webinar "Understanding Monochorionic Diamniotic Twins: Complications and Outcomes" with Vickie A. Feldstein, MD and Nasim Sobhani, MD — register today: https://t.co/4pvx4r7IOe
Join us Sept 29th, Wednesday for our webinar on Fetal Therapies for Single-Gene Disorders with Tippi Mackenzie, MD and Billie Lianoglou, LCGC, MS. Register here: https://t.co/QjxiCsVzxp
Members of our Fetal Treatment Center team will be running in the @CMNTorchRelay charity run! Our goal is to raise funds to support parking and gas for our patients. Help support us and our patients by donating here! https://t.co/fV2U9Nj6Jl
Exciting news! UCSF Fetal treatment center phase 1 clinical trial about In Utero Enzyme Replacement Therapy for Fetuses with Lysosomal Storage Diseases is officially open to enrollment.
Please check our website for more info:
https://t.co/U70baSTkXs
@MackenzieTippi@UCSFfetal
Join us Sept 29th, Wednesday for our webinar on Fetal Therapies for Single-Gene Disorders with Tippi Mackenzie, MD and Billie Lianoglou, LCGC, MS. Register here: https://t.co/QjxiCsVzxp
We've launched our new Fetal Treatment Center website! Our main goals with the new site was to make it cleaner with easier navigation and provide a greater focus on all of our research initiatives! https://t.co/fRkDjeTy1R
Great work, Dr. Swanson! Publication describing the high desire for secondary findings among parents undergoing exome sequencing for their fetus or child.
@UCSF_ObGynRS@UCSFcmfpm@pndxdoc
https://t.co/kOScDuqtmO
Researchers found a way to double accuracy in detecting most fetal heart birth defects -- the most common kind of birth defect -- by using machine learning. @arnaoutlab@UCSFCardiology@UCSF_BCHSI@UCSF_Ci2
https://t.co/1X54btsVYj